🇺🇸 FDA
Patent

US 7488804

Modified fusion molecules for treatment of allergic disease

granted A61PA61P37/08

Quick answer

US patent 7488804 (Modified fusion molecules for treatment of allergic disease) held by The Regents of the University of California expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P37/08